The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.
Saved in:
| Title: | The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells. |
|---|---|
| Authors: | Maharaj K; Department of Malignant Hematology.; Department of Immunology, and.; Department of Cancer Biology PhD Program, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Powers JJ; Department of Immunology, and., Achille A; Department of Immunology, and., Mediavilla-Varela M; Department of Malignant Hematology.; Department of Immunology, and., Gamal W; Department of Immunology, and.; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL., Burger KL; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Fonseca R; Department of Immunology, and., Jiang K; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Miskin HP; TG Therapeutics, Inc., New York, NY., Maryanski D; TG Therapeutics, Inc., New York, NY., Monastyrskyi A; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and., Duckett DR; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and., Roush WR; Department of Molecular Medicine, The Scripps Research Institute, Scripps Florida, Jupiter, FL., Cleveland JL; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Sahakian E; Department of Malignant Hematology.; Department of Immunology, and., Pinilla-Ibarz J; Department of Malignant Hematology.; Department of Immunology, and. |
| Source: | Blood advances [Blood Adv] 2020 Jul 14; Vol. 4 (13), pp. 3072-3084. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32634240 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Maharaj+K%22">Maharaj K</searchLink>; Department of Malignant Hematology.; Department of Immunology, and.; Department of Cancer Biology PhD Program, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Powers+JJ%22">Powers JJ</searchLink>; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Achille+A%22">Achille A</searchLink>; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Mediavilla-Varela+M%22">Mediavilla-Varela M</searchLink>; Department of Malignant Hematology.; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Gamal+W%22">Gamal W</searchLink>; Department of Immunology, and.; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Burger+KL%22">Burger KL</searchLink>; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Fonseca+R%22">Fonseca R</searchLink>; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Jiang+K%22">Jiang K</searchLink>; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Miskin+HP%22">Miskin HP</searchLink>; TG Therapeutics, Inc., New York, NY.<br /><searchLink fieldCode="AU" term="%22Maryanski+D%22">Maryanski D</searchLink>; TG Therapeutics, Inc., New York, NY.<br /><searchLink fieldCode="AU" term="%22Monastyrskyi+A%22">Monastyrskyi A</searchLink>; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and.<br /><searchLink fieldCode="AU" term="%22Duckett+DR%22">Duckett DR</searchLink>; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and.<br /><searchLink fieldCode="AU" term="%22Roush+WR%22">Roush WR</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, Scripps Florida, Jupiter, FL.<br /><searchLink fieldCode="AU" term="%22Cleveland+JL%22">Cleveland JL</searchLink>; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Sahakian+E%22">Sahakian E</searchLink>; Department of Malignant Hematology.; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Pinilla-Ibarz+J%22">Pinilla-Ibarz J</searchLink>; Department of Malignant Hematology.; Department of Immunology, and. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2020 Jul 14; Vol. 4 (13), pp. 3072-3084. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32634240 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2020001800 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3072 Titles: – TitleFull: The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Maharaj K – PersonEntity: Name: NameFull: Powers JJ – PersonEntity: Name: NameFull: Achille A – PersonEntity: Name: NameFull: Mediavilla-Varela M – PersonEntity: Name: NameFull: Gamal W – PersonEntity: Name: NameFull: Burger KL – PersonEntity: Name: NameFull: Fonseca R – PersonEntity: Name: NameFull: Jiang K – PersonEntity: Name: NameFull: Miskin HP – PersonEntity: Name: NameFull: Maryanski D – PersonEntity: Name: NameFull: Monastyrskyi A – PersonEntity: Name: NameFull: Duckett DR – PersonEntity: Name: NameFull: Roush WR – PersonEntity: Name: NameFull: Cleveland JL – PersonEntity: Name: NameFull: Sahakian E – PersonEntity: Name: NameFull: Pinilla-Ibarz J IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 07 Text: 2020 Jul 14 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 4 – Type: issue Value: 13 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |